Skip to Main Content

Author Details

Yi-Mi Wu
University of Michigan Medical School ann arbor
1995
78
38
PMIDPaper TitleJournal TitlePublished Year
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37377606Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.Cancer Res Commun2023
36103645Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.JCO Precis Oncol2022
35644065Homozygous ATM mutation due to germline uniparental isodisomy in patient with T acute lymphoblastic leukemia and hepatosplenic T-cell lymphoma.Cancer Genet2022
33310900Targeting transcriptional regulation of SARS-CoV-2 entry factors <i>ACE2</i> and <i>TMPRSS2</i>.Proc Natl Acad Sci U S A2021
33630025Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol2021
33753452Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.Clin Cancer Res2021
34003562Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation.Pediatr Blood Cancer2021
32154134Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.Transl Pediatr2020
33283137Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study.JCO Precis Oncol2020
32605311Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.Cancers (Basel)2020
33015523Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers.JCO Precis Oncol2020
29554022Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.J Pediatr Hematol Oncol2019
31647501Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.JAMA Ophthalmol2019
32832834DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric Oncology.JCO Precis Oncol2019
31243372Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.Nature2019
30712214Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.Med Oncol2019
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
30735636The Landscape of Circular RNA in Cancer.Cell2019
31061129Genomic correlates of clinical outcome in advanced prostate cancer.Proc Natl Acad Sci U S A2019
29233927Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.Cancer Res2018
32832831Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.JCO Precis Oncol2018
32832832Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.JCO Precis Oncol2018
32832830Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor.JCO Precis Oncol2018
29906450Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.Cell2018
29899824Clinical validation of the Tempus xO assay.Oncotarget2018
29610475The long tail of oncogenic drivers in prostate cancer.Nat Genet2018
29572239Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.Cold Spring Harb Mol Case Stud2018
29261439Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.J Clin Oncol2018
27866206Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells.J Innate Immun2017
28335073Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.Am J Hematol2017
28423517Next generation sequencing of extraskeletal myxoid chondrosarcoma.Oncotarget2017
28783718Integrative clinical genomics of metastatic cancer.Nature2017
28751446Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.Clin Cancer Res2017
28860053Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.Transl Res2017
27167109A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Oncotarget2016
26404914A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall.Histol Histopathol2016
26257279Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.Pediatr Blood Cancer2016
27582545Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.Oncotarget2016
25599403The landscape of long noncoding RNAs in the human transcriptome.Nat Genet2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
26253700The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.Genome Res2015
26325560Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.JAMA2015
26510020DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.N Engl J Med2015
26238782The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.Cancer Res2015
26063736The landscape of antisense gene expression in human cancers.Genome Res2015
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
25754347ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells.Clin Cancer Res2015
25822367Targeting the MLL complex in castration-resistant prostate cancer.Nat Med2015
  • 1 - 50 of 78

Recommended Authors

Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 10
Qi Zhao
University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 14
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 8
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 10
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 0
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 0
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 9
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 11
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 15
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 32
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 4
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 6
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 20
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 2
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 22
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 3
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 19
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 8
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 9
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 27
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 33
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 21
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 43

Collaborators

Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 55
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 53
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 39
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 29
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 20
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 19
Chandan Kumar-Sinha
Co-authored papers 16
Rajen Mody
Co-authored papers 16
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 14
Marcin Cieslik
Co-authored papers 13
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 12
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 12
Saravana M Dhanasekaran
Co-authored papers 10
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 10
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 10
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers 8
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 8
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 8
John R Prensner
University of Michigan ann arbor
Co-authored papers 8
Susana Miranda
The Institute of Cancer Research
Co-authored papers 7
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 7
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 7
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 6
Mark A Rubin
University of Bern
Co-authored papers 6
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers 6
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 5
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 5
Release 1.2